Financial goals

  • Senzime shall become a market leader in the peri- and post-operative neuromuscular monitoring segment, with a long-term global market share of at least 10%.
  • Senzime shall reach at least SEK 200 million in revenue in 2023, corresponding to a sales increase of 100% vs. 2022.
  • Senzime shall reach profitability during 2023.